What is ENTX's current stock price?

ENTX (Entera Bio Ltd.) is currently trading at $1.24 with a market cap of $61.0M.

What sector is Entera Bio Ltd. in?

Entera Bio Ltd. (ENTX) operates in the Healthcare sector, specifically in the Biotechnology industry.

InvestLog

ENTX Entera Bio Ltd.

Healthcare

$1.24-2.36%ClosedMarket Cap: $61.0M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

—

PEG

—

P/B

5.54

P/S

0.00

EV/EBITDA

-4.62

DCF Value

$0.14

FCF Yield

-15.7%

Div Yield

0.0%

Margins & Returns

Gross Margin

0.0%

Operating Margin

0.0%

Net Margin

0.0%

ROE

-88.0%

ROA

-94.3%

ROIC

-106.5%

Financials

View All

Period	Revenue	Net Income	EPS
Q1 null	$0.00	$-3.5M	$—
Q4 null	$0.00	$-3.0M	$—
FY null	$42.0K	$-11.4M	$—
Q3 null	$0.00	$-3.2M	$—

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$—

Target (Median)

$—

Target Range

$— - $—

0 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell

HC Wainwright & Co.Buy

2026-04-27

HC Wainwright & Co.Buy

2026-02-09

Trading Activity

Insider Trades

View All

Yaacov-Garbeli Danaofficer: Chief Financial Officer

SellFri May 08

Galitzer Hillelofficer: Chief Operating Officer

SellFri May 08

Burshtein Gregoryofficer: Chief of R&D

SellFri May 08

Germano Geno Jdirector

BuyWed Mar 11

Ellis Seandirector

BuyMon Mar 09

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

Exchange

—

Beta

1.55

Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed Phase II clinical trials for the treatment of osteoporosis, as well as is in Phase I clinical trials for the treatment of non-union fractures. The company has a research collaboration and license agreement with the Amgen Inc. for the development and discovery of clinical candidates in the field of inflammatory disease and other serious illnesses. Entera Bio Ltd. was incorporated in 2009 and is based in Jerusalem, Israel.

Peers

INO

IRD